The benefit of immunotherapy in patients with metastatic breast cancer is...
The possibility of performing surgical resection for non-small-cell lung cancer...
The CheckMate 9LA study has already demonstrated the significant benefit of...
During the 2023 edition of ELCC, Dr Mariana Brandao from the Institut Jules...
Dr Charlotte De Bondt from the University Hospital Antwerp comments on the...
During the ELCC Congress 2023 in Copenhagen, Prof Em Johan Van Steenkiste (UZ...
During our reports at the European Lung Cancer Congress 2023 in Copenhagen, the...
The POLAR signature is a genetic classifier to define benefit of breast cancer...
The 4-year follow up data of a pre-planned overall survival analysis of the...